Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Pharmacy Times" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Pharmacy Times for you to read. Along with our medical data and news we also list Pharmacy Times Clinical Trials, which are updated daily. BioPortfolio also has a large database of Pharmacy Times Companies for you to search.
The study was aimed at the efficacy and safety of cerliponase alfa (Brineura, BioMarin) for patients with CLN2.
Officials with the FDA have approved Novartis’ triclabendazole (Egaten) for the treatment of fascioliasis, also known as liver fluke infestation, in patients age 6 years and older.
Ryan, who was elected as the 54th Speaker of the House in 2015 and served in that role until January 2019 will speak as part of the Business Program, scheduled for Tuesday April 30.
An FDA program is seeking to facilitate better quality drug manufacturing through recognized consensus standards.
Camber recently announced the FDA approval of Tolterodine Tartrate ER capsules, a generic version of Detrol LA (tolterodine, Pharmacia & Upjohn).
Daratumumab was first approved in November 2015 as the first and only CD38-directed antibody for the treatment of patients with multiple myeloma who have received at least 3 prior lines of therapy, including a proteasome inhibitor (PI) and an immunomodulatory agent, or who are double refractory to both.
Although many pharmacists are divided when it comes to their job satisfaction, most of them are currently happy with their compensation, according to a recent Pharmacy Times® Salary and Job Satisfaction Survey.
The collaborating drug companies cut prices in an effort to make their drugs more accessible.
Warning letters and online advisory letters were posted to the agency's website for 58 products, mostly dietary supplements.
Researchers predict that the changing nature of the epidemic, driven by the illegal use of opioids such as heroin and fentanyl, has reduced the potential impact of programs that target prescription opioids.
The program aims to reduce the amount of illegal or suspect prescription drugs distributed throughout the United States.
Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education for retail, health-system, managed care and specialty pharmacists, has announced the ninth annual Directions in Pharmacy® continuing education conference series, which will take place in 4 major cities across the United States in spring 2019.
A recent study analyzed how health systems utilize and integrate virtual care into their daily practice.
Officials with the FDA have approved caplacizumab-yhdp (Cablivi, Sanofi) injection for the treatment of adults with acquired thrombotic thrombocytopenic purpura (aTTP), a rare and life-threatening blood clotting autoimmune disorder.
A New Drug Application (NDA) and a supplemental NDA (sNDA) were accepted for the Priority Review for products being developed by Merck.
Dr. Reddy’s Laboratories is continuing its voluntary nationwide recall of the antiepileptic drug Levetiracetram in 0.54% Sodium Chloride Injection, 1,500 mg/100 mL (15 mg/mL) in single-dose infusion bags to the hospital level in the United States.
The FDA is warning patients and doctors that certain test strips used to monitor levels of the blood thinner warfarin may provide inaccurate results and should not be relied upon to adjust the drug dosage.
Officials with the FDA have expanded the label of pemetrexed for injection (Alimta, Eli Lilly) in combination with pembrolizumab (Keytruda, Merck) and platinum chemotherapy.
The 'polar vortex' that gripped much of the country this week has not stopped pharmacists from helping patients.
The affected lots have been found to contain levels of ibuprofen concentration that are higher than the specified limit.
The FDA has approved sumatriptan nasal spray (Tosymra, Promius Pharma) for the acute treatment of migraine with or without aura in adults.
The FDA has approved the use of ibrutinib (Imbruvica®, AbbVie) in combination with obinutuzumab (Gazyva®) for adult patients with previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
Health Mart has named Nimesh Jhaveri, MBA, RPh, its new president.
Can you solve the pharmaceutical mystery?
One lot of irbesartan and 7 lots of irbesartan and hydrochlorothiazide (HCTZ) combination tablets distributed by Solco Healthcare, a Prinston Pharmaceutical subsidiary are affected.